WHO ICTRP trial
Effect of nalbuphine on the EC50 and EC95 of ropivacaine for epidural labor…
ChiCTR2300076379 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300076379 |
|---|---|
| Public title | Effect of nalbuphine on the EC50 and EC95 of ropivacaine for epidural labor analgesia |
| Scientific title | Effect of nalbuphine on the EC50 and EC95 of ropivacaine for epidural labor analgesia |
| Primary sponsor | Women's Hospital School of Medicine Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Labor Pain |
| Interventions | Group1:nalbuphine 0.1mg/ml;Group2:nalbuphine 0.15mg/ml;Group3:nalbuphine 0.2mg/ml;Group4:nalbuphine 0.25mg/ml;Group5:nalbuphine 0.3mg/ml;Control group:None |
| Registration date | Oct 7, 2023 |
| Target size | Group1:30;Group2:30;Group3:30;Group4:30;Group5:30;Control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: